PCD franchise & third-party manufacturing directory · listings since 2016
Cardiac & Diabetic · Anti-diabetics: SGLT2 inhibitors
This page lists dapagliflozin PCD franchise offers from companies with diabetic ranges. It is meant for distributors and ex-MRs who visit physicians and diabetologists and want plain or combined tablets with area rights.
5 Dapagliflozin products
1 Dapagliflozin product
4 Dapagliflozin products
10 Dapagliflozin products
8 Dapagliflozin products
7 Dapagliflozin products
6 Dapagliflozin products
4 Dapagliflozin products
Showing 10 of 17
Dapagliflozin belongs to the gliflozin group of oral anti-diabetic medicines. It works through the kidneys and is a prescription product that doctors use for blood sugar control, often alongside other diabetes medicines.
The molecule is a regular part of diabetologist and physician prescriptions in cities and growing towns, and some cardiologists write it as well. Chemists near diabetes clinics and multispecialty hospitals usually stock more than one brand, so presence and steady supply matter. For a franchise partner, that means a molecule with regular repeat prescriptions, provided the brand stays available without gaps in every chemist you supply.
Most listings are film coated tablets, with a few capsules. The common pairings seen in company ranges are:
A diabetes range sells on follow up, so pick a company that also offers metformin, glimepiride, gliptins and supporting cardiac molecules. Compare PTR against local market rates and work out your real margin. Make sure monopoly rights cover the area you can actually service. Look at blister foil quality and carton design, since doctors notice them. Ask about shelf life at dispatch, the return policy for expiry and the visual aids, reminder cards and samples the company gives for doctor calls.
Brand owners should share the exact composition and strength they need, whether a plain or combined product, pack style such as alu alu or blister, and the minimum batch size. Ask for stability studies, process validation records and the product permission held by the plant for that combination. Check that the plant holds a valid manufacturing licence and meets revised Schedule M. Since new combinations can need regulatory approval, confirm the product is already approved before you plan your launch.
Related pages: Cardiac & Diabetic PCD Franchise and all molecules A to Z. Often combined with: Metformin, Sitagliptin, Vildagliptin.
